Skip to main content
TipRanks
Go Ultimate75% OFF

Arrowhead Pharmaceuticals (0HI3) Ownership - Who Owns Arrowhead Pharmaceuticals?

0 Followers

Arrowhead Pharmaceuticals (0HI3) Ownership Overview

  • 3.64% Insiders
  • 21.37% Mutual Funds
  • 36.15% Other Institutional Investors
  • 24.68% ETFs
  • 14.16% Public Companies and Individual Investors

The ownership structure of Arrowhead Pharmaceuticals (GB:0HI3) stock is a mix of institutional, retail, and individual investors. Approximately 82.20% of the company’s stock is owned by Institutional Investors, 3.64% is owned by Insiders, and 14.16% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 19, 2026Adeoye Olukotun$173,920
Aug 19, 2026Michael S. Perry$1,012,680
Dec 18, 2025Christopher Richard Anzalone$5,443,462
Dec 15, 2025Christopher Richard Anzalone$12,348,802

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Graham Capital Management, L.p.$279,435
Dec 31, 2025Entrypoint Capital, Llc$329,360
Dec 31, 2025Bridgewater Associates, Lp$3,981,142
Dec 31, 2025Platinum Investment Management$5,940,842

Top Shareholders

GB:0HI3 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.15,140,840Institution10.71%648,482,177
Ishares13,437,611Institution9.51%575,532,879
Vanguard10,846,888Institution7.67%464,572,213
Vanguard Index Funds10,698,015Institution7.57%458,195,982
Spdr4,771,050Institution3.37%204,344,072
Fidelity Mt. Vernon Street Trust3,966,507Institution2.81%169,885,495
Christopher Richard Anzalone3,792,739Insider2.68%162,443,011
David Gerald Greenspan2,523,500Institution1.79%108,081,505
Invesco1,950,984Institution1.38%83,560,645
Columbia Funds Series Trust I1,854,834Institution1.31%79,442,540

Top Mutual Fund Holders

GB:0HI3 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds10,698,015Institution7.57%458,195,982
Fidelity Mt. Vernon Street Trust3,966,507Institution2.81%169,885,495
Columbia Funds Series Trust I1,854,834Institution1.31%79,442,540
Fidelity Concord Street Trust1,387,160Institution0.98%59,412,063
Alger Institutional Funds1,127,723Institution0.80%48,300,376
Fidelity Salem Street Trust1,035,058Institution0.73%44,331,534
Alger Funds702,434Institution0.50%30,085,248
Manager Directed Portfolios572,008Institution0.40%24,499,103
Fidelity Select Portfolios474,778Institution0.34%20,334,742
Bridge Builder Trust443,402Institution0.31%18,990,908

FAQ

Who Owns Arrowhead Pharmaceuticals (GB:0HI3)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 82.20% of the company's stock is held by institutional investors, 3.64% is held by insiders, and 14.16% is held by public companies and individual investors.
What percentage of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 82.20% of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by institutional investors: 21.37% by mutual funds, 24.68% by ETFs and 36.15% by other institutional investors.
What percentage of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 14.16% of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by public companies and individual investors.
Who owns the most shares of Arrowhead Pharmaceuticals (GB:0HI3)?
BlackRock, Inc. owns the most shares of Arrowhead Pharmaceuticals (GB:0HI3).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.